Stability of a transdermal salmon calcitonin formulation

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 10, Issue 1, 2003, Pages 41-45

  Chang, Shu Lun ^a   Hofmann, Günter A ^b   Zhang, Lei ^b   Deftos, Leonard J ^c   Banga, Ajay K ^d  

^a AUBURN UNIVERSITY   (United States)

^b Inovio Biomedical Corporation   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MERCER UNIVERSITY   (United States)

Author keywords

Electroporation; Formulation; Iontophoresis; Stability; Transdermal Delivery

Indexed keywords

APROTININ; CALCITONIN; GLASS; SODIUM CHLORIDE;

ADSORPTION; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DIFFUSION; DRUG FORMULATION; DRUG MONITORING; DRUG STABILITY; ELECTRIC FIELD; ELECTRICITY; ELECTROPORATION; HUMAN; HUMAN TISSUE; IONTOPHORESIS; MOLECULAR DYNAMICS; MOLECULAR STABILITY; PH; PRIORITY JOURNAL; PROTEIN DEGRADATION; SALMON; SKIN ABSORPTION; STATISTICAL SIGNIFICANCE; SURFACE PROPERTY;

EID: 0037275857     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.1080/713840326     Document Type: Article

References (13)

1. Arvinte, T., and Drake, A. F. 1993. Comparative study of human and salmon calcitonin secondary structure in solutions with low dielectric constants. J. Biol. Chem. 268(9):6408-6414.
2. Banga, A. K. 1998. Electrically Assisted Transdermal and Topical Drug Delivery. London: Taylor & Francis, 1-172.
3. Banga, A. K., and Prausnitz, M. R. 1998. Assessing the potential of skin electroporation for the delivery of protein- and gene-based drugs. Trends Biotechnol. 16:408-412.
4. Chang, S., Hofmann, G. A., Zhang, L., Deftos, L. J., and Banga, A. K. 2000a. The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones. J. Control. Rel. 66:127-133.
5. Chang, S., Hofmann, G. A., Zhang, L., Deftos, L. J., and Banga, A. K. 2000b. Transdermal iontophoretic delivery of salmon calcitonin. Int. J. Pharm. 200:107-113.
6. Deftos, L. J. 1998. Clinical Essentials of Calcium and Skeletal Disorders. Caddo, OK: Professional Communications, 1-314.
7. Heinitz, M. L., Flanigan, E., Orlowski, R. C., and Regnier, F. E. 1988. Correlation of calcitonin structure with chromatographic retention in high performance liquid chromatography. J. Chromatogr. 443:229-245.
8. Lee, K. C., Lee, Y. J., Song, H. M., Chun, C. J., and DeLuca, P. P. 1992. Degradation of synthetic salmon calcitonin in aqueous solution. Pharm. Res. 9:1521-1523.
9. Santi, P. P., Colombo, P., Bettini, R., Catellani, P. L., Minutello, A., and Volpato, N. M. 1997. Drug reservoir composition and transport of salmon calcitonin in transdermal iontophoresis. Pharm. Res. 14(1):63-66.
10. Steinstrasser, I., Koopmann, K., and Merkle, H. P. 1997. Epidermal aminopeptidase activity and metabolism as observed in an organized HaCaT cell sheet model. J. Pharm. Sci. 86:378-383.
11. Thysman, S., Hanchard, C., and Preat, V. 1994. Human calcitonin delivery in rats by iontophoresis. J. Pharm. Pharmacol. 46:725-730.
12. Tomohira, Y., Machida, Y., Onishi, H., and Nagai, T. 1997. Iontophoretic transdermal absorption of insulin and calcitonin in rats with newly-devised switching technique and addition of urea. Int. J. Pharm. 155:231-239.
13. Windisch, V., DeLuccia, F., Duhau, L., Herman, F., Mencel, J. J., Tang, S. Y., and Vuilhorgne, M. 1997. Degradation pathways of salmon calcitonin in aqueous solution. J. Pharm. Sci. 86:359-364.